In vitro analysis of tobramycin-treated Pseudomonas aeruginosa biofilms on cystic fibrosis-derived airway epithelial cells.

Infection and Immunity
Gregory G AndersonGeorge A O'Toole

Abstract

P. aeruginosa forms biofilms in the lungs of individuals with cystic fibrosis (CF); however, there have been no effective model systems for studying biofilm formation in the CF lung. We have developed a tissue culture system for growth of P. aeruginosa biofilms on CF-derived human airway cells that promotes the formation of highly antibiotic-resistant microcolonies, which produce an extracellular polysaccharide matrix and require the known abiotic biofilm formation genes flgK and pilB. Treatment of P. aeruginosa biofilms with tobramycin reduced the virulence of the biofilms both by reducing bacterial numbers and by altering virulence gene expression. We performed microarray analysis of these biofilms on epithelial cells after treatment with tobramycin, and we compared these results with gene expression of (i) tobramycin-treated planktonic P. aeruginosa and (ii) tobramycin-treated P. aeruginosa biofilms on an abiotic surface. Despite the conservation in functions required to form a biofilm, our results show that the responses to tobramycin treatment of biofilms grown on biotic versus abiotic surfaces are different, as exemplified by downregulation of genes involved in Pseudomonas quinolone signal biosynthesis specifically in epi...Continue Reading

References

Apr 1, 1988·Antimicrobial Agents and Chemotherapy·W W NicholsH L Walmsley
Jan 1, 1994·American Journal of Respiratory Cell and Molecular Biology·A L CozensD C Gruenert
Apr 1, 1993·Clinical Microbiology Reviews·C M Litwin, S B Calderwood
Jan 1, 1995·Annual Review of Microbiology·J W CostertonH M Lappin-Scott
Nov 15, 1997·Applied and Environmental Microbiology·G V BloembergR Kolter
Nov 5, 1999·Methods in Enzymology·G A O'TooleR Kolter
Oct 10, 2001·Journal of Bacteriology·L A Gallagher, C Manoil
Oct 26, 2001·Nature·M WhiteleyE P Greenberg
Jan 25, 2002·Journal of Bacteriology·Karin SauerDavid G Davies
Apr 5, 2002·Clinical Microbiology Reviews·Jeffrey B LyczakGerald B Pier
Jun 12, 2002·Current Opinion in Microbiology·Staffan Kjelleberg, Soeren Molin
Oct 14, 2003·American Journal of Respiratory and Critical Care Medicine·Ronald L GibsonBonnie W Ramsey
Nov 25, 2003·Nature·Thien-Fah MahGeorge A O'Toole
Jan 17, 2004·Clinical Microbiology Reviews·Lisa Saiman, Jane Siegel
Jan 24, 2004·The European Respiratory Journal·R C Boucher
Jun 4, 2004·Journal of Bacteriology·Chung-Dar LuWei Li
Sep 25, 2004·Molecular Microbiology·Hiromi Sato, Dara W Frank
Oct 16, 2004·Expert Review of Anti-infective Therapy·Sang Sun Yoon, Daniel J Hassett
Nov 24, 2004·Molecular Microbiology·Deborah A HoganRoberto Kolter
Nov 24, 2004·Infection and Immunity·Ciara M Shaver, Alan R Hauser
Feb 8, 2005·American Journal of Respiratory and Critical Care Medicine·Ruxana T SadikotAlice S Prince
Jul 19, 2005·Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society·N HøibyT Pressler
Aug 2, 2005·Clinical Orthopaedics and Related Research·Robin Patel
Feb 3, 2006·Journal of Bacteriology·S FurukawaG A O'Toole
May 6, 2006·American Journal of Respiratory and Critical Care Medicine·Timothy D StarnerPaul B McCray
Jul 4, 2006·Journal of Bacteriology·Amy L SpoeringKim Lewis
Jul 6, 2006·Applied and Environmental Microbiology·Robert M Q ShanksGeorge A O'Toole
Sep 26, 2006·Molecular Microbiology·Timothy L Yahr, Matthew C Wolfgang

❮ Previous
Next ❯

Citations

Apr 5, 2012·Proceedings of the National Academy of Sciences of the United States of America·Amy K BarczakDeborah T Hung
Jun 1, 2010·Journal of Bacteriology·Christophe S BernardEric Cascales
May 15, 2013·Journal of Bacteriology·Angelyca A JacksonDeborah A Hogan
Jul 24, 2012·American Journal of Physiology. Lung Cellular and Molecular Physiology·Thomas H HamptonBruce A Stanton
Jan 27, 2009·American Journal of Respiratory Cell and Molecular Biology·Sophie Moreau-MarquisBruce A Stanton
Nov 19, 2010·BMC Microbiology·James P FolsomPhilip S Stewart
Oct 26, 2010·Journal of Visualized Experiments : JoVE·Sophie Moreau-MarquisGregory G Anderson
Dec 19, 2012·Journal of Microbiological Methods·Michele J AndersonMarnie L Peterson
Nov 14, 2013·Journal of Aerosol Medicine and Pulmonary Drug Delivery·Mohamed Al-AloulMartin Walshaw
Dec 3, 2014·Advanced Drug Delivery Reviews·Marius HittingerClaus-Michael Lehr
Mar 19, 2011·European Journal of Pharmacology·Shigeki NakamuraShigeru Kohno
Jul 21, 2009·Pulmonary Pharmacology & Therapeutics·Alexander ChuchalinFederico Bianco
Mar 26, 2016·Frontiers in Microbiology·Hao TanWeihui Wu
May 23, 2012·Biochemistry and Molecular Biology Education : a Bimonthly Publication of the International Union of Biochemistry and Molecular Biology·Carly V RedelmanGregory G Anderson
Apr 29, 2014·The Journal of Pathology·Sashwati RoyChandan K Sen
Feb 12, 2015·Journal of Medical Microbiology·Steven L PercivalGianfranco Donelli
Apr 12, 2014·Microbiology·Barbara M CoffeyGregory G Anderson
Jun 11, 2015·Future Microbiology·Akhilandeswarre DharmaprakashSabu Thomas
Nov 21, 2012·FEMS Immunology and Medical Microbiology·Carly V RedelmanGregory G Anderson
Sep 1, 2014·Archives of Microbiology·Sahar A Alshalchi, Gregory G Anderson
May 21, 2010·FEMS Immunology and Medical Microbiology·Tom Coenye
Jul 26, 2012·FEMS Microbiology Letters·Jinki Yeom, Woojun Park

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Transport Proteins (ASM)

Bacterial transport proteins facilitate active and passive transport of small molecules and solutes across the bacterial membrane. Here is the latest research.

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Bacterial Transport Proteins

Bacterial transport proteins facilitate active and passive transport of small molecules and solutes across the bacterial membrane. Here is the latest research.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.